June 22-25 | San Diego

Loading

From Vision to Value: Private-Led Biotech Market Growth Powered by Saudi Arabia's Agile Ecosystem [Lunch in Room]

June 24, 2026
28ABCDE
Type: Super Session
Focus Area: Emerging Opportunities in Global Markets
Saudi Arabia is rapidly emerging as one of the most compelling pharmaceutical and biotech markets globally. This session brings together global and local industry leaders to explore the deal structures, partnership models, and strategic alignments driving the Kingdom's sector growth from co-development and licensing to technology transfer and joint ventures. Panelists will examine how priorities are evolving, and what it takes to turn partnerships into scalable, lasting value. Real-world success stories will illustrate how Saudi Arabia is cementing its position as a global hub for biotech innovation. Attendees will gain a clearer understanding of where the most promising partnership opportunities lie, what makes deals succeed in the Saudi market, and how to position their organizations to compete and collaborate in one of the region's fastest-growing sectors.
Moderator
Liz Clark
Global Policy Director for India and Middle East, Global Policy and Government Affairs
Bristol Myers Squibb
Speakers
Fadi Al-Buhairan, PhD
Chief Executive Officer
Lifera Group
Abdulaziz Al-Qahtani, PharmD
Pipeline & Market Access Director
Amarox Company
Ahmed Aljedai, Pharm.D., MBA
Vice Chairman and Managing Director
Saudi Pharmaceutical Industry Company (SPIMACO)

Sponsored by:

Upload Image

white squarewhite

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS

Loading